Molecular imaging maps the locations of specific molecules and biomaterials within living tissue. As such, it has the potential to diagnose a disease, to monitor the course of that disease, and possibly facilitate treatment. Molecular imaging has developed into a promising new strategy for the diagnosis, evaluation and treatment of disease.
The final volume in Kalorama's Medical Imaging Markets series: Medical Imaging Markets, Volume V, Molecular Imaging offers complete market coverage of world markets for molecular imaging products for the following technologies:
SPECT-Gamma Camera Systems
Interest in and use of the technology has exploded in recent years, thanks to advances in cell biology, biochemical agents, and computer analysis, and serious market watchers in medical imaging industries, as well as those serving or investing in medical imaging companies, will want to keep abreast of this new market. As part of its comprehensive coverage, Medical Imaging Markets, Volume V, Molecular Imaging includes:
Complete Overview and Explanation of modalities and key applications
Over 35 Figures and Tables to make market data accessible to users.
Review of Imaging Agents in Clinical Trials, or that are recently introduced.
Market Size and Forecasts are developed through 2011.
Profiles of Top Competitors in the industry including: including Gamma Medica, GE Healthcare, Hiatchi, OptoSonics, Philips, Siemens and Toshiba, among others.
Kalorama looks at the technologies currently used in molecular imaging but also examines novel research areas, such as:
PET Targets Alzheimer’s Disease
PET Diagnoses Pancreas Defects
Molecular Breast Imaging
Radiotracers and Drug Addiction
PET/CT for Ovarian Cancer
SPECT for Lower Back Pain
As part of Kalorama's trusted information-gathering process, the information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence with medical imaging company executives were the primary method of gathering information and developing forecasts.